89 related articles for article (PubMed ID: 24984202)
1. The outcome of targeted therapies in patients with poor prognosis metastatic renal cell carcinoma.
Giuliani J; Marzola M
Cancer Biother Radiopharm; 2014 Sep; 29(7):298-300. PubMed ID: 24984202
[No Abstract] [Full Text] [Related]
2. Prognostic implication of extrarenal metabolic tumor burden in advanced renal cell carcinoma treated with targeted therapy after nephrectomy.
Yoon HJ; Paeng JC; Kwak C; Park YH; Kim TM; Lee SH; Chung JK; Edmund Kim E; Lee DS
Ann Nucl Med; 2013 Oct; 27(8):748-55. PubMed ID: 23818007
[TBL] [Abstract][Full Text] [Related]
3. Erythrocyte sedimentation rate kinetics as a marker of treatment response and predictor of prognosis in Chinese metastatic renal cell carcinoma patients treated with sorafenib.
Zhang HL; Zhu Y; Wang CF; Yao XD; Zhang SL; Dai B; Shen YJ; Zhu YP; Shi GH; Ye DW
Int J Urol; 2011 Jun; 18(6):422-30. PubMed ID: 21481012
[TBL] [Abstract][Full Text] [Related]
4. Current and emerging first-line systemic therapies in clear cell renal cell carcinoma.
Rini BI
Clin Adv Hematol Oncol; 2018 Feb; 16(2):115-117. PubMed ID: 29741511
[No Abstract] [Full Text] [Related]
5. The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study.
Ko JJ; Xie W; Kroeger N; Lee JL; Rini BI; Knox JJ; Bjarnason GA; Srinivas S; Pal SK; Yuasa T; Smoragiewicz M; Donskov F; Kanesvaran R; Wood L; Ernst DS; Agarwal N; Vaishampayan UN; Rha SY; Choueiri TK; Heng DY
Lancet Oncol; 2015 Mar; 16(3):293-300. PubMed ID: 25681967
[TBL] [Abstract][Full Text] [Related]
6. Targeted therapies in advanced renal cell carcinoma: the role of metastatic sites as a prognostic factor.
Grassi P; Verzoni E; Porcu L; Testa I; Iacovelli R; Torri V; Braud Fd; Procopio G
Future Oncol; 2014 Jun; 10(8):1361-72. PubMed ID: 25052747
[TBL] [Abstract][Full Text] [Related]
7. Complete response to interferon-alpha in a patient with metastatic renal cell carcinoma after unsuccessful molecular-targeted therapies.
Yamamoto T; Kitamura H; Masumori N
Int J Urol; 2014 Aug; 21(8):839-40. PubMed ID: 24635538
[No Abstract] [Full Text] [Related]
8. [Renal cell cancer].
Németh I; Iványi B; Pajor L
Orv Hetil; 2006 Jul; 147(28):1336-7. PubMed ID: 16999021
[No Abstract] [Full Text] [Related]
9. The value of cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy.
You D; Jeong IG; Ahn JH; Lee DH; Lee JL; Hong JH; Ahn H; Kim CS
J Urol; 2011 Jan; 185(1):54-9. PubMed ID: 21074811
[TBL] [Abstract][Full Text] [Related]
10. Outcome of patients with metastatic sarcomatoid renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Kyriakopoulos CE; Chittoria N; Choueiri TK; Kroeger N; Lee JL; Srinivas S; Knox JJ; Bjarnason GA; Ernst SD; Wood LA; Vaishampayan UN; Agarwal N; Pal SK; Kanesvaran R; Rha SY; Yuasa T; Donskov F; North SA; Heng DY; Rini BI
Clin Genitourin Cancer; 2015 Apr; 13(2):e79-85. PubMed ID: 25450036
[TBL] [Abstract][Full Text] [Related]
11. Temsirolimus for patients with metastatic renal cell carcinoma: outcomes in patients receiving temsirolimus within a compassionate use program in a tertiary referral center.
Afshar M; Pascoe J; Whitmarsh S; James N; Porfiri E
Drug Des Devel Ther; 2015; 9():13-9. PubMed ID: 25552898
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of long-term and short-term survivors of metastatic renal cell carcinoma treated with targeted therapies: results from the International mRCC Database Consortium.
Fay AP; Xie WL; Lee JL; Harshman LC; Bjarnason GA; Knox JJ; Ernst S; Wood L; Vaishamayan UN; Yuasa T; Tan MH; Rha SY; Donskov F; Agarwal N; Kollmannsberger CK; North SA; Rini BI; Choueiri TK; Heng DY
Clin Genitourin Cancer; 2015 Apr; 13(2):150-5. PubMed ID: 25458371
[TBL] [Abstract][Full Text] [Related]
13. Comparison of survival rates in patients with metastatic renal cell carcinoma according to treatment era including cytokine and targeted therapy.
Takagi T; Kondo T; Kennoki T; Iizuka J; Kobayashi H; Hashimoto Y; Tanabe K
Jpn J Clin Oncol; 2013 Apr; 43(4):439-43. PubMed ID: 23303839
[TBL] [Abstract][Full Text] [Related]
14. Continuing education: The emergence of thalidomide in treating advanced renal cell carcinoma.
Wood LS; Perez C; Monroe D
Oncol Nurs Forum; 2003; 30(3):501-11. PubMed ID: 12719749
[TBL] [Abstract][Full Text] [Related]
15. Sorafenib induces therapeutic response in a patient with metastatic collecting duct carcinoma of kidney.
Ansari J; Fatima A; Chaudhri S; Bhatt RI; Wallace M; James ND
Onkologie; 2009 Feb; 32(1-2):44-6. PubMed ID: 19209019
[TBL] [Abstract][Full Text] [Related]
16. Bevacizumab as first-line therapy for patients with brain metastases from renal carcinoma: a case series.
Zustovich F; Ferro A; Farina P
Clin Genitourin Cancer; 2014 Jun; 12(3):e107-10. PubMed ID: 24583162
[No Abstract] [Full Text] [Related]
17. Time from nephrectomy as a prognostic factor in metastatic renal cell carcinoma patients receiving targeted therapies: overall results from a large cohort of patients.
Procopio G; Testa I; Verzoni E; Iacovelli R; Grassi P; Galli G; De Braud F; Saravia D; Salvioni R
Oncology; 2015; 88(3):133-8. PubMed ID: 25377648
[TBL] [Abstract][Full Text] [Related]
18. First-line treatment result influence second-line regimen selection in targeted therapy for metastatic renal cell carcinoma.
Li JR; Yang CK; Wang SS; Chen CS; Chiu KY; Cheng CL; Yang CR; Ho HC; Ko JL; Ou YC
Anticancer Res; 2014 Oct; 34(10):5643-7. PubMed ID: 25275068
[TBL] [Abstract][Full Text] [Related]
19. [Difficulties in histopathologic diagnosis of the metastases of the renal clear cell carcinoma to the nasal cavity].
Szyfter W; Manasterski J; Turczuk-Bierła I
Otolaryngol Pol; 1993; 47(3):295-8. PubMed ID: 8414550
[No Abstract] [Full Text] [Related]
20. Kidney cancer. Clinical practice guidelines.
Motzer RJ; Carducci MA; Fishman M; Hancock SL; Hauke RJ; Hudes GR; Kantoff P; Kuzel TM; Lange PH; Levine EG; Logothetis C; Margolin KA; Pili R; Pohar KS; Redman BG; Richey S; Robertson CN; Samlowski WE; Sheinfeld J; Urban DA;
J Natl Compr Canc Netw; 2005 Jan; 3(1):84-93. PubMed ID: 19813325
[No Abstract] [Full Text] [Related]
[Next] [New Search]
